Posted by - UniqueThis
-
on - Feb 24 -
Filed in - Other -
-
26 Views -
0 Comments -
0 Likes -
0 Reviews
Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year, the Danish drugmaker said on Tuesday